510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K032791Substantially Equivalent

Glycohemosure Hba1c Control

Quantimetrix Corp., Redondo Beach CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)510(k) summary (opens on fda.gov)

K032791 is the FDA 510(k) clearance record for GLYCOHEMOSURE HBA1C CONTROL, a class II device, cleared for Quantimetrix Corp. on under FDA product code GGM (Control, Hemoglobin). FDA records list 39 510(k) clearances for Quantimetrix Corp., from to . As of , FDA records show no recalls naming K032791.

Clearance record

Decision date
Received
(52 days to decision)
Product code
GGM Control, Hemoglobin
Regulation
21 CFR 864.8625
Device class
Class II
Review panel
Hematology
Applicant
Quantimetrix Corp. 2005 Manhattan Beach Blvd., Redondo Beach CA
510(k) summary
Summary PDF
Third party review
No

Clearances, product code GGM

Trailing 12 months

FDA records hold no clearances under product code GGM in the trailing twelve months.

FDA records show no clearances under product code GGM in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code GGM, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260